ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
17.932,17
-1,10%
S&P 500
5.018,39
-0,34%
Dow Jones
37.903,29
0,23%
Euro vs US Dollar
1,07164
0,47%
Bitcoin
58.460,04
0,38%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. BioCryst Pharmaceuticals Inc (BCRX)

  7. BioCryst Pharmaceuticals Inc (BCRX) News

BCRX BioCryst Pharmaceuticals Inc

4,59
0,46 (11,14%)
Nach Börsenschluss
Zuletzt aktualisiert: 01:12:07
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
BioCryst Pharmaceuticals Inc BCRX NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,46 11,14% 4,59 01:12:07
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
4,18 4,15 4,77 4,57 4,13
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
22.4.202413:00GLOBEBioCryst to Report First Quarter 2024 Financial Results on..
17.4.202410:30GLOBEBioCryst Announces Approval of ORLADEYO® (berotralstat) by..
03.4.202413:00GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
25.3.202421:01GLOBEBioCryst to Present at Upcoming Investor Conferences
05.3.202413:01GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
04.3.202423:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.3.202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202423:05EDGAR2Form S-3ASR - Automatic shelf registration statement of..
26.2.202413:05EDGAR2Form 8-K - Current report
26.2.202413:00GLOBEBioCryst Reports Fourth Quarter and Full Year 2023 Financial..
26.2.202411:57IHMARKETNEWSU.S. Index Futures Dip Amid Inflation Data Anticipation, Oil..
23.2.202413:00GLOBEBioCryst Presents New Real-world Data Showing Rapid,..
21.2.202422:01GLOBEBioCryst to Present at Upcoming Investor Conferences
19.2.202413:54GLOBEBioCryst Launches ORLADEYO® (berotralstat) in Italy
14.2.202422:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14.2.202415:02EDGAR2Form SC 13G - Statement of acquisition of beneficial..
12.2.202413:00GLOBEBioCryst to Report Fourth Quarter 2023 Financial Results on..
05.2.202413:00GLOBEBioCryst to Present New ORLADEYO® (berotralstat) Real-world..
02.2.202413:00GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
24.1.202423:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
18.1.202423:21EDGAR2Form 8-K - Current report
08.1.202413:02EDGAR2Form 8-K - Current report
05.1.202422:01GLOBEBioCryst Announces Preliminary Full Year 2023 ORLADEYO®..
04.1.202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202422:01GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
03.1.202413:00GLOBEBioCryst to Present at 42nd Annual J.P. Morgan Healthcare..
20.12.202322:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.12.202322:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.12.202322:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.12.202322:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.12.202322:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.12.202313:00GLOBEBioCryst Announces Publication of Data from Open-label..
18.12.202322:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.12.202322:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.12.202322:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.12.202322:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.12.202322:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.12.202322:01GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
01.12.202322:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.12.202322:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.12.202313:37EDGAR2Form 8-K - Current report
30.11.202315:04EDGAR2Form 8-K - Current report
29.11.202313:00GLOBEBioCryst Announces Approval of ORLADEYO® (berotralstat) by..
21.11.202322:01GLOBEBioCryst to Present at Upcoming Investor Conferences
21.11.202313:00GLOBEBioCryst Launches ORLADEYO® (berotralstat) in Spain
10.11.202313:00GLOBEBioCryst Presents New Real-world Data Showing Reduced Attack..
08.11.202322:29EDGAR2Form S-8 - Securities to be offered to employees in employee..
08.11.202322:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06.11.202322:01GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
03.11.202317:16EDGAR2Form 8-K - Current report

Kürzlich von Ihnen besucht

NASDAQ
BCRX
BioCryst Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten